好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting Virtual Experience | S4 - Abstracts of Distinction 4

Tuesday 04/26/22
04:00 PM - 05:08 PM EDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Stefano Sandrone, PhD, Shadi Yaghi, MD
Cerebrovascular Disease and Interventional Neurology, History of Neurology, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Neuro-rehabilitation, 好色先生, Research, and Methodology, Health Care Disparities
Abstracts of distinction are top abstracts wihtin each topic presented in an oral format. Presentations are eight minutes in length with additional question and answer time during the session with the authors.
1.00 CME credit
Diversity, Equity, and Inclusion

Program Materials Program Evaluations

Event Timeline
04:00 PM - 04:08 PM EDT Speaker Online Modules Support a Neurology Resident Teleneurology Curriculum - Pilot Data
Shivika Chandra, MD, FAAN
04:08 PM - 04:16 PM EDT Speaker Trends in Diversity at a Single US Adult Neurology Residency Program
Keiko A. Fukuda, MD
04:16 PM - 04:24 PM EDT Speaker Deep Learning Can Accurately Distinguish Between True Papilledema and Optic Disc Drusen On Ocular Fundus Photographs
Valerie Biousse, MD
04:24 PM - 04:32 PM EDT Speaker Stem Cell Factor as a Novel Diagnostic Plasma Biomarker for Glioblastoma Multiforme Patients
Amirhosein Kefayat, MD
04:32 PM - 04:38 PM EDT Q&A Q&A
Shivika Chandra, MD, FAAN, Amirhosein Kefayat, MD, Keiko A. Fukuda, MD, Valerie Biousse, MD
04:38 PM - 04:46 PM EDT Speaker “Stranger than fiction”: the nineteenth-century media coverage of the case of Phineas Gage
Manon Auffret, PhD, PharmD
04:46 PM - 04:54 PM EDT Speaker Loss of Regained or Spared Function after SCI (Neuroworsening): Evidence and Dimension
Markus E. Harrigan
04:54 PM - 05:02 PM EDT Speaker Clinical pharmacy services as part of the Telehealth After Stroke Care in an underserved setting: a feasibility study
Yuliya Baratt, PharmD, BCPS
05:02 PM - 05:08 PM EDT Q&A Q&A
Manon Auffret, PhD, PharmD, Markus E. Harrigan, Yuliya Baratt, PharmD, BCPS
Faculty Disclosures
Valerie Biousse, MD Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Shadi Yaghi, MD Dr. Yaghi has nothing to disclose.
Stefano Sandrone, PhD Dr. Sandrone has nothing to disclose.
Keiko A. Fukuda, MD Dr. Fukuda has nothing to disclose.
Shivika Chandra, MD, FAAN The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in 好色先生 Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Manon Auffret, PhD, PharmD Dr. Auffret has received personal compensation for serving as an employee of France Développement Electronique. The institution of Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Britannia. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aguettant. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Auffret has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Britannia. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Auffret has received research support from Association France Parkinson. The institution of Dr. Auffret has received research support from Homeperf. The institution of Dr. Auffret has received research support from LVL. The institution of Dr. Auffret has received research support from University of Rennes. The institution of Dr. Auffret has received research support from Aguettant. The institution of Dr. Auffret has received research support from Linde. The institution of Dr. Auffret has received research support from Plateforme Nationale pour la recherche sur la fin de vie. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care.
Amirhosein Kefayat, MD Mr. Kefayat has nothing to disclose.
Markus E. Harrigan Mr. Harrigan has nothing to disclose.
Yuliya Baratt, PharmD, BCPS Dr. Baratt has nothing to disclose.